effects. You may report side effects to FDA at 1-800-FDA-1088.
How should I store LENVIMA?
Store LENVIMA at room temperature, between 68°F to 77°F (20°C to 25°C).
Keep LENVIMA and all medicines out of the reach of children.
General information about the safe and effective use of LENVIMA.
Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use LENVIMA for a condition for which it was not prescribed. Do not give LENVIMA to other people, even if they have the same symptoms you have. It may harm them. You can ask your healthcare provider or pharmacist for information about LENVIMA that is written for health professionals.
What are the ingredients in LENVIMA?
Active ingredient: lenvatinib
Inactive ingredients: calcium carbonate, mannitol, microcrystalline cellulose, hydroxypropylcellulose, hydroxypropylcellulose (type H), and talc.
The capsule shell contains: titanium dioxide, ferric oxide yellow, and ferric oxide red. The printing ink contains shellac, black iron oxide, potassium hydroxide, and propylene glycol.
Distributed by: Eisai Inc., Woodcliff Lake, NJ 07677
LENVIMA® is a registered trademark of Eisai R&D Management Co., Ltd. and is licensed to Eisai Inc.
For more information, call 1-877-873-4724 or go to www.LENVIMA.com.
This Patient Information has been approved by the U.S. Food and Drug Administration. Revised: 08/2016CLOSE
PRINCIPAL DISPLAY PANEL
PRINCIPAL DISPLAY PANEL
NDC 62856-708-05
Lenvima
(lenvatinib) capsules
8 mg daily dose
NDC 62856-708-05
Lenvima
(lenvatinib) capsules
8 mg daily dose
PRINCIPAL DISPLAY PANEL
PRINCIPAL DISPLAY PANEL
NDC 62856-710-30
Lenvima
(lenvatinib) capsules
10 mg daily dose
30 day supply
10 mg daily- dose carton containing 6 cards
NDC 62856-710-30
Lenvima
(lenvatinib) capsules
10 mg daily dose
30 day supply
10 mg daily- dose carton containing 6 cards
PRINCIPAL DISPLAY PANEL
PRINCIPAL DISPLAY PANEL
NDC 62856-714-30
Lenvima
(lenvatinib) capsules
14 mg daily dose
30 day supply
14 mg daily- dose carton containing 6 cards
NDC 62856-714-30
Lenvima
(lenvatinib) capsules
14 mg daily dose
30 day supply
14 mg daily- dose carton containing 6 cards
PRINCIPAL DISPLAY PANEL
PRINCIPAL DISPLAY PANEL
NDC 62856-718-30
Lenvima
(lenvatinib) capsules
18 mg daily dose
NDC 62856-718-30
Lenvima
(lenvatinib) capsules
18 mg daily dose
PRINCIPAL DISPLAY PANEL
PRINCIPAL DISPLAY PANEL
NDC 62856-720-30
Lenvima
(lenvatinib) capsules
20 mg daily dose
30 day supply
20 mg daily- dose carton containing 6 cards
NDC 62856-720-30
Lenvima
(lenvatinib) capsules
20 mg daily dose
30 day supply
20 mg daily- dose carton containing 6 cards
PRINCIPAL DISPLAY PANEL
PRINCIPAL DISPLAY PANEL
NDC 62856-724-30
Lenvima
(lenvatinib) capsules
24 mg daily dose
30 day supply
24 mg daily- dose carton containing 6 cards
NDC 62856-724-30
Lenvima
(lenvatinib) capsules
24 mg daily dose
30 day supply
24 mg daily- dose carton containing 6 cards
INGREDIENTS AND APPEARANCE
LENVIMA
lenvatinib capsule
PRODUCT INFORMATION
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:62856-710
Route of Administration ORAL
ACTIVE INGREDIENT/AC |
